nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluvastatin—UGT2B7—Mycophenolic acid—psoriasis	0.0739	0.096	CbGbCtD
Fluvastatin—UGT1A1—Mycophenolic acid—psoriasis	0.0639	0.083	CbGbCtD
Fluvastatin—CYP1A1—Clobetasol propionate—psoriasis	0.0601	0.078	CbGbCtD
Fluvastatin—SLCO1B3—Mycophenolate mofetil—psoriasis	0.0424	0.0551	CbGbCtD
Fluvastatin—UGT2B7—Mycophenolate mofetil—psoriasis	0.0413	0.0536	CbGbCtD
Fluvastatin—UGT1A1—Mycophenolate mofetil—psoriasis	0.0357	0.0464	CbGbCtD
Fluvastatin—CYP1A1—Methoxsalen—psoriasis	0.0316	0.041	CbGbCtD
Fluvastatin—CYP2C8—Tazarotene—psoriasis	0.0283	0.0367	CbGbCtD
Fluvastatin—CYP3A5—Beclomethasone—psoriasis	0.0273	0.0355	CbGbCtD
Fluvastatin—CYP1A2—Clobetasol propionate—psoriasis	0.0268	0.0349	CbGbCtD
Fluvastatin—SLCO1B1—Mycophenolate mofetil—psoriasis	0.0247	0.0321	CbGbCtD
Fluvastatin—CYP1A1—Cholecalciferol—psoriasis	0.0209	0.0272	CbGbCtD
Fluvastatin—SLCO1B1—Cyclosporine—psoriasis	0.0187	0.0243	CbGbCtD
Fluvastatin—SLCO1B3—Methotrexate—psoriasis	0.017	0.0221	CbGbCtD
Fluvastatin—CYP2B6—Cholecalciferol—psoriasis	0.0159	0.0207	CbGbCtD
Fluvastatin—CYP1A2—Methoxsalen—psoriasis	0.0141	0.0183	CbGbCtD
Fluvastatin—CYP2D6—Hydroxyurea—psoriasis	0.0127	0.0165	CbGbCtD
Fluvastatin—CYP2C8—Cholecalciferol—psoriasis	0.0121	0.0157	CbGbCtD
Fluvastatin—CYP3A5—Mycophenolate mofetil—psoriasis	0.0109	0.0141	CbGbCtD
Fluvastatin—CYP2C8—Mycophenolate mofetil—psoriasis	0.0105	0.0136	CbGbCtD
Fluvastatin—CYP2C19—Cholecalciferol—psoriasis	0.0101	0.0131	CbGbCtD
Fluvastatin—SLCO1B1—Methotrexate—psoriasis	0.00991	0.0129	CbGbCtD
Fluvastatin—CYP3A4—Calcitriol—psoriasis	0.0095	0.0123	CbGbCtD
Fluvastatin—CYP1A1—Dexamethasone—psoriasis	0.00905	0.0117	CbGbCtD
Fluvastatin—CYP3A5—Hydrocortisone—psoriasis	0.00873	0.0113	CbGbCtD
Fluvastatin—CYP2C9—Cholecalciferol—psoriasis	0.00841	0.0109	CbGbCtD
Fluvastatin—CYP2C8—Hydrocortisone—psoriasis	0.00839	0.0109	CbGbCtD
Fluvastatin—CYP3A5—Cyclosporine—psoriasis	0.00824	0.0107	CbGbCtD
Fluvastatin—CYP2C8—Cyclosporine—psoriasis	0.00793	0.0103	CbGbCtD
Fluvastatin—CYP2D6—Cholecalciferol—psoriasis	0.00769	0.00999	CbGbCtD
Fluvastatin—CYP3A4—Methoxsalen—psoriasis	0.00739	0.00959	CbGbCtD
Fluvastatin—CYP2C19—Prednisone—psoriasis	0.00702	0.00911	CbGbCtD
Fluvastatin—CYP2B6—Dexamethasone—psoriasis	0.00689	0.00895	CbGbCtD
Fluvastatin—CYP2C19—Cyclosporine—psoriasis	0.00665	0.00864	CbGbCtD
Fluvastatin—CYP2C9—Cyclosporine—psoriasis	0.00553	0.00718	CbGbCtD
Fluvastatin—CYP3A5—Dexamethasone—psoriasis	0.00543	0.00705	CbGbCtD
Fluvastatin—CYP2C8—Dexamethasone—psoriasis	0.00522	0.00678	CbGbCtD
Fluvastatin—CYP2D6—Cyclosporine—psoriasis	0.00506	0.00657	CbGbCtD
Fluvastatin—CYP3A4—Cholecalciferol—psoriasis	0.00489	0.00635	CbGbCtD
Fluvastatin—CYP2C19—Dexamethasone—psoriasis	0.00438	0.00569	CbGbCtD
Fluvastatin—CYP3A4—Triamcinolone—psoriasis	0.00424	0.00551	CbGbCtD
Fluvastatin—CYP3A4—Mycophenolate mofetil—psoriasis	0.00424	0.00551	CbGbCtD
Fluvastatin—CYP2C9—Dexamethasone—psoriasis	0.00364	0.00473	CbGbCtD
Fluvastatin—CYP3A4—Betamethasone—psoriasis	0.00364	0.00473	CbGbCtD
Fluvastatin—CYP3A4—Prednisolone—psoriasis	0.00359	0.00466	CbGbCtD
Fluvastatin—CYP3A4—Hydrocortisone—psoriasis	0.0034	0.00442	CbGbCtD
Fluvastatin—CYP3A4—Prednisone—psoriasis	0.00339	0.0044	CbGbCtD
Fluvastatin—CYP2D6—Dexamethasone—psoriasis	0.00333	0.00432	CbGbCtD
Fluvastatin—CYP3A4—Cyclosporine—psoriasis	0.00321	0.00418	CbGbCtD
Fluvastatin—CYP3A4—Dexamethasone—psoriasis	0.00212	0.00275	CbGbCtD
Fluvastatin—SLCO1B1—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000441	0.0115	CbGpPWpGaD
Fluvastatin—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	0.000418	0.0109	CbGpPWpGaD
Fluvastatin—CYP3A4—Xenobiotics—CYP2S1—psoriasis	0.00041	0.0107	CbGpPWpGaD
Fluvastatin—HMGCR—Integrated Breast Cancer Pathway—ZMIZ1—psoriasis	0.000387	0.0101	CbGpPWpGaD
Fluvastatin—UGT1A3—Biological oxidations—CYP2S1—psoriasis	0.000375	0.0098	CbGpPWpGaD
Fluvastatin—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000375	0.00978	CbGpPWpGaD
Fluvastatin—UGT1A3—Metapathway biotransformation—CYP2S1—psoriasis	0.00037	0.00966	CbGpPWpGaD
Fluvastatin—CYP2B6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.00037	0.00965	CbGpPWpGaD
Fluvastatin—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000366	0.00956	CbGpPWpGaD
Fluvastatin—CYP3A5—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000361	0.00943	CbGpPWpGaD
Fluvastatin—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000346	0.00903	CbGpPWpGaD
Fluvastatin—CYP1A1—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000341	0.00891	CbGpPWpGaD
Fluvastatin—HMGCR—PPARA activates gene expression—CARM1—psoriasis	0.000322	0.00839	CbGpPWpGaD
Fluvastatin—UGT2B7—Biological oxidations—CYP2S1—psoriasis	0.000319	0.00833	CbGpPWpGaD
Fluvastatin—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000317	0.00828	CbGpPWpGaD
Fluvastatin—UGT2B7—Metapathway biotransformation—CYP2S1—psoriasis	0.000315	0.00822	CbGpPWpGaD
Fluvastatin—HMGCR—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CARM1—psoriasis	0.000315	0.00822	CbGpPWpGaD
Fluvastatin—CYP2C8—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000313	0.00817	CbGpPWpGaD
Fluvastatin—CYP2B6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000304	0.00793	CbGpPWpGaD
Fluvastatin—CYP3A5—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000297	0.00775	CbGpPWpGaD
Fluvastatin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	0.000289	0.00754	CbGpPWpGaD
Fluvastatin—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000283	0.00739	CbGpPWpGaD
Fluvastatin—CYP1A1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.00028	0.00732	CbGpPWpGaD
Fluvastatin—CYP2C19—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000279	0.00729	CbGpPWpGaD
Fluvastatin—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.00026	0.0068	CbGpPWpGaD
Fluvastatin—UGT1A1—Biological oxidations—CYP2S1—psoriasis	0.000259	0.00677	CbGpPWpGaD
Fluvastatin—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000258	0.00674	CbGpPWpGaD
Fluvastatin—CYP2C8—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000257	0.00671	CbGpPWpGaD
Fluvastatin—CYP2D6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000257	0.00671	CbGpPWpGaD
Fluvastatin—UGT1A1—Metapathway biotransformation—CYP2S1—psoriasis	0.000256	0.00668	CbGpPWpGaD
Fluvastatin—CYP2C9—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000255	0.00665	CbGpPWpGaD
Fluvastatin—CYP2C19—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.00023	0.00599	CbGpPWpGaD
Fluvastatin—HMGCR—AMPK Signaling—LEP—psoriasis	0.000223	0.00583	CbGpPWpGaD
Fluvastatin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000221	0.00576	CbGpPWpGaD
Fluvastatin—CYP1A2—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000218	0.00568	CbGpPWpGaD
Fluvastatin—HMGCR—Fatty acid, triacylglycerol, and ketone body metabolism—CARM1—psoriasis	0.000217	0.00566	CbGpPWpGaD
Fluvastatin—CYP2D6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000211	0.00551	CbGpPWpGaD
Fluvastatin—CYP2C9—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000209	0.00546	CbGpPWpGaD
Fluvastatin—UGT1A3—NRF2 pathway—TGFA—psoriasis	0.000209	0.00546	CbGpPWpGaD
Fluvastatin—HMGCR—SREBP signalling—PPARG—psoriasis	0.000194	0.00507	CbGpPWpGaD
Fluvastatin—CYP1A1—Oxidative Stress—CAT—psoriasis	0.000181	0.00472	CbGpPWpGaD
Fluvastatin—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	0.00018	0.00469	CbGpPWpGaD
Fluvastatin—CYP1A2—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000179	0.00467	CbGpPWpGaD
Fluvastatin—UGT2B7—NRF2 pathway—TGFA—psoriasis	0.000178	0.00464	CbGpPWpGaD
Fluvastatin—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000172	0.00449	CbGpPWpGaD
Fluvastatin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.00017	0.00444	CbGpPWpGaD
Fluvastatin—CYP1A1—Estrogen Receptor Pathway—JUN—psoriasis	0.00017	0.00443	CbGpPWpGaD
Fluvastatin—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000168	0.00439	CbGpPWpGaD
Fluvastatin—SLCO2B1—SLC-mediated transmembrane transport—CP—psoriasis	0.000167	0.00435	CbGpPWpGaD
Fluvastatin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	0.000166	0.00433	CbGpPWpGaD
Fluvastatin—CYP2B6—Biological oxidations—CYP2S1—psoriasis	0.000161	0.00421	CbGpPWpGaD
Fluvastatin—CYP2B6—Metapathway biotransformation—CYP2S1—psoriasis	0.000159	0.00415	CbGpPWpGaD
Fluvastatin—CYP3A5—Biological oxidations—CYP2S1—psoriasis	0.000158	0.00412	CbGpPWpGaD
Fluvastatin—CYP3A5—Metapathway biotransformation—CYP2S1—psoriasis	0.000156	0.00406	CbGpPWpGaD
Fluvastatin—UGT1A3—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	0.000155	0.00406	CbGpPWpGaD
Fluvastatin—CYP1A1—Biological oxidations—CYP2S1—psoriasis	0.000149	0.00389	CbGpPWpGaD
Fluvastatin—CYP1A1—Metapathway biotransformation—CYP2S1—psoriasis	0.000147	0.00384	CbGpPWpGaD
Fluvastatin—CYP1A1—Estrogen Receptor Pathway—STAT3—psoriasis	0.000147	0.00383	CbGpPWpGaD
Fluvastatin—CYP1A1—Melatonin metabolism and effects—APOE—psoriasis	0.000144	0.00377	CbGpPWpGaD
Fluvastatin—UGT1A1—NRF2 pathway—TGFA—psoriasis	0.000144	0.00377	CbGpPWpGaD
Fluvastatin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000138	0.0036	CbGpPWpGaD
Fluvastatin—CYP2C8—Biological oxidations—CYP2S1—psoriasis	0.000137	0.00357	CbGpPWpGaD
Fluvastatin—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000136	0.00355	CbGpPWpGaD
Fluvastatin—CYP2C8—Metapathway biotransformation—CYP2S1—psoriasis	0.000135	0.00352	CbGpPWpGaD
Fluvastatin—HMGCR—PPARA activates gene expression—PPARG—psoriasis	0.000134	0.00349	CbGpPWpGaD
Fluvastatin—HMGCR—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—psoriasis	0.000131	0.00342	CbGpPWpGaD
Fluvastatin—SLCO1B3—SLC-mediated transmembrane transport—CP—psoriasis	0.00013	0.0034	CbGpPWpGaD
Fluvastatin—SLC15A1—SLC-mediated transmembrane transport—CP—psoriasis	0.000129	0.00338	CbGpPWpGaD
Fluvastatin—CYP1A1—Tryptophan metabolism—CAT—psoriasis	0.000129	0.00336	CbGpPWpGaD
Fluvastatin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	0.000124	0.00324	CbGpPWpGaD
Fluvastatin—CYP2C19—Biological oxidations—CYP2S1—psoriasis	0.000122	0.00318	CbGpPWpGaD
Fluvastatin—CYP2C19—Metapathway biotransformation—CYP2S1—psoriasis	0.00012	0.00314	CbGpPWpGaD
Fluvastatin—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.00012	0.00313	CbGpPWpGaD
Fluvastatin—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000119	0.0031	CbGpPWpGaD
Fluvastatin—CYP2C19—Melatonin metabolism and effects—APOE—psoriasis	0.000118	0.00309	CbGpPWpGaD
Fluvastatin—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	0.000116	0.00304	CbGpPWpGaD
Fluvastatin—CYP2D6—Biological oxidations—CYP2S1—psoriasis	0.000112	0.00293	CbGpPWpGaD
Fluvastatin—CYP2C9—Biological oxidations—CYP2S1—psoriasis	0.000111	0.0029	CbGpPWpGaD
Fluvastatin—CYP2D6—Metapathway biotransformation—CYP2S1—psoriasis	0.000111	0.00289	CbGpPWpGaD
Fluvastatin—CYP2C9—Metapathway biotransformation—CYP2S1—psoriasis	0.00011	0.00286	CbGpPWpGaD
Fluvastatin—CYP2D6—Melatonin metabolism and effects—APOE—psoriasis	0.000109	0.00284	CbGpPWpGaD
Fluvastatin—CYP1A2—Estrogen Receptor Pathway—JUN—psoriasis	0.000108	0.00282	CbGpPWpGaD
Fluvastatin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	0.000107	0.0028	CbGpPWpGaD
Fluvastatin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	0.000106	0.00276	CbGpPWpGaD
Fluvastatin—CYP1A1—PPARA activates gene expression—CARM1—psoriasis	0.000104	0.00272	CbGpPWpGaD
Fluvastatin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CARM1—psoriasis	0.000102	0.00266	CbGpPWpGaD
Fluvastatin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000101	0.00264	CbGpPWpGaD
Fluvastatin—CYP1A2—Biological oxidations—CYP2S1—psoriasis	9.5e-05	0.00248	CbGpPWpGaD
Fluvastatin—CYP1A2—Metapathway biotransformation—CYP2S1—psoriasis	9.37e-05	0.00245	CbGpPWpGaD
Fluvastatin—CYP1A2—Estrogen Receptor Pathway—STAT3—psoriasis	9.35e-05	0.00244	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism—NDUFA5—psoriasis	9.26e-05	0.00242	CbGpPWpGaD
Fluvastatin—CYP1A2—Melatonin metabolism and effects—APOE—psoriasis	9.21e-05	0.0024	CbGpPWpGaD
Fluvastatin—HMGCR—AMPK Signaling—TP53—psoriasis	9.1e-05	0.00238	CbGpPWpGaD
Fluvastatin—HMGCR—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—psoriasis	9.03e-05	0.00236	CbGpPWpGaD
Fluvastatin—SLCO1B1—SLC-mediated transmembrane transport—CP—psoriasis	8.74e-05	0.00228	CbGpPWpGaD
Fluvastatin—Paraesthesia—Prednisolone—psoriasis	8.72e-05	0.000455	CcSEcCtD
Fluvastatin—Mental disorder—Prednisone—psoriasis	8.71e-05	0.000454	CcSEcCtD
Fluvastatin—Erythema—Prednisone—psoriasis	8.65e-05	0.000451	CcSEcCtD
Fluvastatin—Musculoskeletal discomfort—Hydrocortisone—psoriasis	8.64e-05	0.000451	CcSEcCtD
Fluvastatin—HMGCR—Metabolism of lipids and lipoproteins—CARM1—psoriasis	8.64e-05	0.00225	CbGpPWpGaD
Fluvastatin—Hyperhidrosis—Triamcinolone—psoriasis	8.64e-05	0.00045	CcSEcCtD
Fluvastatin—CYP1A1—Melatonin metabolism and effects—NFKB1—psoriasis	8.59e-05	0.00224	CbGpPWpGaD
Fluvastatin—Feeling abnormal—Mycophenolate mofetil—psoriasis	8.58e-05	0.000448	CcSEcCtD
Fluvastatin—Insomnia—Hydrocortisone—psoriasis	8.58e-05	0.000447	CcSEcCtD
Fluvastatin—Hypertension—Dexamethasone—psoriasis	8.58e-05	0.000447	CcSEcCtD
Fluvastatin—Hypertension—Betamethasone—psoriasis	8.58e-05	0.000447	CcSEcCtD
Fluvastatin—Paraesthesia—Hydrocortisone—psoriasis	8.52e-05	0.000444	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	8.52e-05	0.000444	CcSEcCtD
Fluvastatin—Urticaria—Cyclosporine—psoriasis	8.48e-05	0.000442	CcSEcCtD
Fluvastatin—SLCO2B1—Transmembrane transport of small molecules—CP—psoriasis	8.47e-05	0.00221	CbGpPWpGaD
Fluvastatin—Myalgia—Betamethasone—psoriasis	8.46e-05	0.000441	CcSEcCtD
Fluvastatin—Myalgia—Dexamethasone—psoriasis	8.46e-05	0.000441	CcSEcCtD
Fluvastatin—Abdominal pain—Cyclosporine—psoriasis	8.44e-05	0.00044	CcSEcCtD
Fluvastatin—Body temperature increased—Cyclosporine—psoriasis	8.44e-05	0.00044	CcSEcCtD
Fluvastatin—Anxiety—Dexamethasone—psoriasis	8.43e-05	0.000439	CcSEcCtD
Fluvastatin—Anxiety—Betamethasone—psoriasis	8.43e-05	0.000439	CcSEcCtD
Fluvastatin—Vomiting—Mycophenolic acid—psoriasis	8.39e-05	0.000438	CcSEcCtD
Fluvastatin—CYP1A1—Oxidative Stress—NFKB1—psoriasis	8.36e-05	0.00218	CbGpPWpGaD
Fluvastatin—Discomfort—Betamethasone—psoriasis	8.35e-05	0.000436	CcSEcCtD
Fluvastatin—Discomfort—Dexamethasone—psoriasis	8.35e-05	0.000436	CcSEcCtD
Fluvastatin—Dyspepsia—Hydrocortisone—psoriasis	8.35e-05	0.000436	CcSEcCtD
Fluvastatin—Rash—Mycophenolic acid—psoriasis	8.32e-05	0.000434	CcSEcCtD
Fluvastatin—Dermatitis—Mycophenolic acid—psoriasis	8.31e-05	0.000433	CcSEcCtD
Fluvastatin—Pain—Prednisolone—psoriasis	8.31e-05	0.000433	CcSEcCtD
Fluvastatin—Hepatitis—Methotrexate—psoriasis	8.3e-05	0.000433	CcSEcCtD
Fluvastatin—Urticaria—Mycophenolate mofetil—psoriasis	8.27e-05	0.000431	CcSEcCtD
Fluvastatin—Headache—Mycophenolic acid—psoriasis	8.27e-05	0.000431	CcSEcCtD
Fluvastatin—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	8.27e-05	0.00216	CbGpPWpGaD
Fluvastatin—Decreased appetite—Hydrocortisone—psoriasis	8.25e-05	0.00043	CcSEcCtD
Fluvastatin—Pharyngitis—Methotrexate—psoriasis	8.24e-05	0.00043	CcSEcCtD
Fluvastatin—Abdominal pain—Mycophenolate mofetil—psoriasis	8.23e-05	0.000429	CcSEcCtD
Fluvastatin—Body temperature increased—Mycophenolate mofetil—psoriasis	8.23e-05	0.000429	CcSEcCtD
Fluvastatin—CYP1A2—Tryptophan metabolism—CAT—psoriasis	8.2e-05	0.00214	CbGpPWpGaD
Fluvastatin—Gastrointestinal disorder—Hydrocortisone—psoriasis	8.19e-05	0.000427	CcSEcCtD
Fluvastatin—Fatigue—Hydrocortisone—psoriasis	8.18e-05	0.000427	CcSEcCtD
Fluvastatin—Musculoskeletal discomfort—Triamcinolone—psoriasis	8.14e-05	0.000424	CcSEcCtD
Fluvastatin—Pain—Hydrocortisone—psoriasis	8.11e-05	0.000423	CcSEcCtD
Fluvastatin—Anaphylactic shock—Betamethasone—psoriasis	8.11e-05	0.000423	CcSEcCtD
Fluvastatin—Anaphylactic shock—Dexamethasone—psoriasis	8.11e-05	0.000423	CcSEcCtD
Fluvastatin—Insomnia—Triamcinolone—psoriasis	8.08e-05	0.000421	CcSEcCtD
Fluvastatin—SLCO2B1—Transmembrane transport of small molecules—CARM1—psoriasis	8.08e-05	0.00211	CbGpPWpGaD
Fluvastatin—Infection—Dexamethasone—psoriasis	8.05e-05	0.00042	CcSEcCtD
Fluvastatin—Infection—Betamethasone—psoriasis	8.05e-05	0.00042	CcSEcCtD
Fluvastatin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	8.04e-05	0.0021	CbGpPWpGaD
Fluvastatin—Ill-defined disorder—Prednisone—psoriasis	8.03e-05	0.000419	CcSEcCtD
Fluvastatin—Paraesthesia—Triamcinolone—psoriasis	8.02e-05	0.000418	CcSEcCtD
Fluvastatin—Feeling abnormal—Prednisolone—psoriasis	8.01e-05	0.000417	CcSEcCtD
Fluvastatin—Visual impairment—Methotrexate—psoriasis	8e-05	0.000417	CcSEcCtD
Fluvastatin—Shock—Betamethasone—psoriasis	7.98e-05	0.000416	CcSEcCtD
Fluvastatin—Shock—Dexamethasone—psoriasis	7.98e-05	0.000416	CcSEcCtD
Fluvastatin—Dyspnoea—Triamcinolone—psoriasis	7.96e-05	0.000415	CcSEcCtD
Fluvastatin—Nervous system disorder—Betamethasone—psoriasis	7.95e-05	0.000415	CcSEcCtD
Fluvastatin—Nervous system disorder—Dexamethasone—psoriasis	7.95e-05	0.000415	CcSEcCtD
Fluvastatin—Thrombocytopenia—Betamethasone—psoriasis	7.94e-05	0.000414	CcSEcCtD
Fluvastatin—Thrombocytopenia—Dexamethasone—psoriasis	7.94e-05	0.000414	CcSEcCtD
Fluvastatin—Angioedema—Prednisone—psoriasis	7.9e-05	0.000412	CcSEcCtD
Fluvastatin—HMGCR—Metabolism—CYP2S1—psoriasis	7.88e-05	0.00206	CbGpPWpGaD
Fluvastatin—Hypersensitivity—Cyclosporine—psoriasis	7.87e-05	0.00041	CcSEcCtD
Fluvastatin—Dyspepsia—Triamcinolone—psoriasis	7.86e-05	0.00041	CcSEcCtD
Fluvastatin—Erythema multiforme—Methotrexate—psoriasis	7.85e-05	0.000409	CcSEcCtD
Fluvastatin—Nausea—Mycophenolic acid—psoriasis	7.84e-05	0.000409	CcSEcCtD
Fluvastatin—Hyperhidrosis—Dexamethasone—psoriasis	7.84e-05	0.000409	CcSEcCtD
Fluvastatin—Hyperhidrosis—Betamethasone—psoriasis	7.84e-05	0.000409	CcSEcCtD
Fluvastatin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	7.82e-05	0.00204	CbGpPWpGaD
Fluvastatin—Feeling abnormal—Hydrocortisone—psoriasis	7.82e-05	0.000408	CcSEcCtD
Fluvastatin—Malaise—Prednisone—psoriasis	7.8e-05	0.000407	CcSEcCtD
Fluvastatin—Vertigo—Prednisone—psoriasis	7.77e-05	0.000405	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Hydrocortisone—psoriasis	7.76e-05	0.000405	CcSEcCtD
Fluvastatin—Syncope—Prednisone—psoriasis	7.76e-05	0.000405	CcSEcCtD
Fluvastatin—Anorexia—Dexamethasone—psoriasis	7.73e-05	0.000403	CcSEcCtD
Fluvastatin—Anorexia—Betamethasone—psoriasis	7.73e-05	0.000403	CcSEcCtD
Fluvastatin—Urticaria—Prednisolone—psoriasis	7.72e-05	0.000402	CcSEcCtD
Fluvastatin—Cardiac disorder—Methotrexate—psoriasis	7.71e-05	0.000402	CcSEcCtD
Fluvastatin—Fatigue—Triamcinolone—psoriasis	7.7e-05	0.000402	CcSEcCtD
Fluvastatin—Hypersensitivity—Mycophenolate mofetil—psoriasis	7.67e-05	0.0004	CcSEcCtD
Fluvastatin—Asthenia—Cyclosporine—psoriasis	7.66e-05	0.000399	CcSEcCtD
Fluvastatin—Pain—Triamcinolone—psoriasis	7.64e-05	0.000398	CcSEcCtD
Fluvastatin—Loss of consciousness—Prednisone—psoriasis	7.6e-05	0.000396	CcSEcCtD
Fluvastatin—Pruritus—Cyclosporine—psoriasis	7.55e-05	0.000394	CcSEcCtD
Fluvastatin—UGT1A3—Metabolism—NDUFA5—psoriasis	7.55e-05	0.00197	CbGpPWpGaD
Fluvastatin—Urticaria—Hydrocortisone—psoriasis	7.54e-05	0.000393	CcSEcCtD
Fluvastatin—Angiopathy—Methotrexate—psoriasis	7.53e-05	0.000393	CcSEcCtD
Fluvastatin—Immune system disorder—Methotrexate—psoriasis	7.5e-05	0.000391	CcSEcCtD
Fluvastatin—Abdominal pain—Hydrocortisone—psoriasis	7.5e-05	0.000391	CcSEcCtD
Fluvastatin—Body temperature increased—Hydrocortisone—psoriasis	7.5e-05	0.000391	CcSEcCtD
Fluvastatin—Asthenia—Mycophenolate mofetil—psoriasis	7.47e-05	0.00039	CcSEcCtD
Fluvastatin—Hypertension—Prednisone—psoriasis	7.47e-05	0.000389	CcSEcCtD
Fluvastatin—Chills—Methotrexate—psoriasis	7.45e-05	0.000389	CcSEcCtD
Fluvastatin—Musculoskeletal discomfort—Dexamethasone—psoriasis	7.39e-05	0.000385	CcSEcCtD
Fluvastatin—Musculoskeletal discomfort—Betamethasone—psoriasis	7.39e-05	0.000385	CcSEcCtD
Fluvastatin—HMGCR—Integrated Breast Cancer Pathway—JUN—psoriasis	7.37e-05	0.00192	CbGpPWpGaD
Fluvastatin—Pruritus—Mycophenolate mofetil—psoriasis	7.37e-05	0.000384	CcSEcCtD
Fluvastatin—Myalgia—Prednisone—psoriasis	7.36e-05	0.000384	CcSEcCtD
Fluvastatin—Arthralgia—Prednisone—psoriasis	7.36e-05	0.000384	CcSEcCtD
Fluvastatin—Feeling abnormal—Triamcinolone—psoriasis	7.36e-05	0.000384	CcSEcCtD
Fluvastatin—Anxiety—Prednisone—psoriasis	7.34e-05	0.000383	CcSEcCtD
Fluvastatin—Alopecia—Methotrexate—psoriasis	7.34e-05	0.000383	CcSEcCtD
Fluvastatin—Insomnia—Dexamethasone—psoriasis	7.33e-05	0.000382	CcSEcCtD
Fluvastatin—Insomnia—Betamethasone—psoriasis	7.33e-05	0.000382	CcSEcCtD
Fluvastatin—CYP3A4—Biological oxidations—CYP2S1—psoriasis	7.33e-05	0.00191	CbGpPWpGaD
Fluvastatin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	7.31e-05	0.000381	CcSEcCtD
Fluvastatin—Diarrhoea—Cyclosporine—psoriasis	7.3e-05	0.000381	CcSEcCtD
Fluvastatin—Paraesthesia—Dexamethasone—psoriasis	7.28e-05	0.00038	CcSEcCtD
Fluvastatin—Paraesthesia—Betamethasone—psoriasis	7.28e-05	0.00038	CcSEcCtD
Fluvastatin—Discomfort—Prednisone—psoriasis	7.28e-05	0.000379	CcSEcCtD
Fluvastatin—Mental disorder—Methotrexate—psoriasis	7.28e-05	0.000379	CcSEcCtD
Fluvastatin—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	7.23e-05	0.00189	CbGpPWpGaD
Fluvastatin—Erythema—Methotrexate—psoriasis	7.23e-05	0.000377	CcSEcCtD
Fluvastatin—Hypersensitivity—Prednisolone—psoriasis	7.16e-05	0.000373	CcSEcCtD
Fluvastatin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	7.14e-05	0.00186	CbGpPWpGaD
Fluvastatin—Dyspepsia—Betamethasone—psoriasis	7.14e-05	0.000372	CcSEcCtD
Fluvastatin—Dyspepsia—Dexamethasone—psoriasis	7.14e-05	0.000372	CcSEcCtD
Fluvastatin—Diarrhoea—Mycophenolate mofetil—psoriasis	7.13e-05	0.000372	CcSEcCtD
Fluvastatin—SLCO1B3—Metabolism—NDUFA5—psoriasis	7.12e-05	0.00186	CbGpPWpGaD
Fluvastatin—Urticaria—Triamcinolone—psoriasis	7.1e-05	0.00037	CcSEcCtD
Fluvastatin—HMGCR—Integrated Breast Cancer Pathway—NFKB1—psoriasis	7.09e-05	0.00185	CbGpPWpGaD
Fluvastatin—Dysgeusia—Methotrexate—psoriasis	7.08e-05	0.000369	CcSEcCtD
Fluvastatin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	7.06e-05	0.00184	CbGpPWpGaD
Fluvastatin—Body temperature increased—Triamcinolone—psoriasis	7.06e-05	0.000368	CcSEcCtD
Fluvastatin—Dizziness—Cyclosporine—psoriasis	7.06e-05	0.000368	CcSEcCtD
Fluvastatin—Anaphylactic shock—Prednisone—psoriasis	7.06e-05	0.000368	CcSEcCtD
Fluvastatin—Decreased appetite—Dexamethasone—psoriasis	7.05e-05	0.000367	CcSEcCtD
Fluvastatin—Decreased appetite—Betamethasone—psoriasis	7.05e-05	0.000367	CcSEcCtD
Fluvastatin—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	7.03e-05	0.00183	CbGpPWpGaD
Fluvastatin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CARM1—psoriasis	7.02e-05	0.00183	CbGpPWpGaD
Fluvastatin—Infection—Prednisone—psoriasis	7.01e-05	0.000366	CcSEcCtD
Fluvastatin—Gastrointestinal disorder—Betamethasone—psoriasis	7e-05	0.000365	CcSEcCtD
Fluvastatin—Gastrointestinal disorder—Dexamethasone—psoriasis	7e-05	0.000365	CcSEcCtD
Fluvastatin—Back pain—Methotrexate—psoriasis	6.99e-05	0.000365	CcSEcCtD
Fluvastatin—Hypersensitivity—Hydrocortisone—psoriasis	6.99e-05	0.000365	CcSEcCtD
Fluvastatin—Fatigue—Betamethasone—psoriasis	6.99e-05	0.000364	CcSEcCtD
Fluvastatin—Fatigue—Dexamethasone—psoriasis	6.99e-05	0.000364	CcSEcCtD
Fluvastatin—Shock—Prednisone—psoriasis	6.95e-05	0.000362	CcSEcCtD
Fluvastatin—Pain—Betamethasone—psoriasis	6.93e-05	0.000361	CcSEcCtD
Fluvastatin—Pain—Dexamethasone—psoriasis	6.93e-05	0.000361	CcSEcCtD
Fluvastatin—Nervous system disorder—Prednisone—psoriasis	6.92e-05	0.000361	CcSEcCtD
Fluvastatin—Dizziness—Mycophenolate mofetil—psoriasis	6.89e-05	0.000359	CcSEcCtD
Fluvastatin—Skin disorder—Prednisone—psoriasis	6.86e-05	0.000358	CcSEcCtD
Fluvastatin—Hyperhidrosis—Prednisone—psoriasis	6.82e-05	0.000356	CcSEcCtD
Fluvastatin—Asthenia—Hydrocortisone—psoriasis	6.81e-05	0.000355	CcSEcCtD
Fluvastatin—Vomiting—Cyclosporine—psoriasis	6.79e-05	0.000354	CcSEcCtD
Fluvastatin—Rash—Cyclosporine—psoriasis	6.73e-05	0.000351	CcSEcCtD
Fluvastatin—Anorexia—Prednisone—psoriasis	6.73e-05	0.000351	CcSEcCtD
Fluvastatin—Dermatitis—Cyclosporine—psoriasis	6.73e-05	0.000351	CcSEcCtD
Fluvastatin—Pruritus—Hydrocortisone—psoriasis	6.71e-05	0.00035	CcSEcCtD
Fluvastatin—Ill-defined disorder—Methotrexate—psoriasis	6.71e-05	0.00035	CcSEcCtD
Fluvastatin—Headache—Cyclosporine—psoriasis	6.69e-05	0.000349	CcSEcCtD
Fluvastatin—Feeling abnormal—Dexamethasone—psoriasis	6.68e-05	0.000348	CcSEcCtD
Fluvastatin—Feeling abnormal—Betamethasone—psoriasis	6.68e-05	0.000348	CcSEcCtD
Fluvastatin—SLCO1B3—Metabolism of lipids and lipoproteins—CARM1—psoriasis	6.63e-05	0.00173	CbGpPWpGaD
Fluvastatin—Gastrointestinal pain—Betamethasone—psoriasis	6.63e-05	0.000346	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Dexamethasone—psoriasis	6.63e-05	0.000346	CcSEcCtD
Fluvastatin—Vomiting—Mycophenolate mofetil—psoriasis	6.62e-05	0.000345	CcSEcCtD
Fluvastatin—SLCO1B3—Transmembrane transport of small molecules—CP—psoriasis	6.61e-05	0.00173	CbGpPWpGaD
Fluvastatin—Hypersensitivity—Triamcinolone—psoriasis	6.58e-05	0.000343	CcSEcCtD
Fluvastatin—SLC15A1—Transmembrane transport of small molecules—CP—psoriasis	6.58e-05	0.00172	CbGpPWpGaD
Fluvastatin—Rash—Mycophenolate mofetil—psoriasis	6.57e-05	0.000342	CcSEcCtD
Fluvastatin—Dermatitis—Mycophenolate mofetil—psoriasis	6.56e-05	0.000342	CcSEcCtD
Fluvastatin—Headache—Mycophenolate mofetil—psoriasis	6.52e-05	0.00034	CcSEcCtD
Fluvastatin—Malaise—Methotrexate—psoriasis	6.52e-05	0.00034	CcSEcCtD
Fluvastatin—Vertigo—Methotrexate—psoriasis	6.49e-05	0.000339	CcSEcCtD
Fluvastatin—Diarrhoea—Hydrocortisone—psoriasis	6.49e-05	0.000339	CcSEcCtD
Fluvastatin—Leukopenia—Methotrexate—psoriasis	6.47e-05	0.000337	CcSEcCtD
Fluvastatin—CYP2D6—Melatonin metabolism and effects—NFKB1—psoriasis	6.47e-05	0.00169	CbGpPWpGaD
Fluvastatin—Urticaria—Dexamethasone—psoriasis	6.44e-05	0.000336	CcSEcCtD
Fluvastatin—Urticaria—Betamethasone—psoriasis	6.44e-05	0.000336	CcSEcCtD
Fluvastatin—HMGCR—Integrated Breast Cancer Pathway—VEGFA—psoriasis	6.44e-05	0.00168	CbGpPWpGaD
Fluvastatin—Musculoskeletal discomfort—Prednisone—psoriasis	6.43e-05	0.000335	CcSEcCtD
Fluvastatin—Dizziness—Prednisolone—psoriasis	6.42e-05	0.000335	CcSEcCtD
Fluvastatin—UGT1A3—Metabolism—CYP2S1—psoriasis	6.42e-05	0.00168	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—NDUFA5—psoriasis	6.42e-05	0.00168	CbGpPWpGaD
Fluvastatin—Asthenia—Triamcinolone—psoriasis	6.41e-05	0.000334	CcSEcCtD
Fluvastatin—Abdominal pain—Dexamethasone—psoriasis	6.41e-05	0.000334	CcSEcCtD
Fluvastatin—Abdominal pain—Betamethasone—psoriasis	6.41e-05	0.000334	CcSEcCtD
Fluvastatin—Body temperature increased—Betamethasone—psoriasis	6.41e-05	0.000334	CcSEcCtD
Fluvastatin—Body temperature increased—Dexamethasone—psoriasis	6.41e-05	0.000334	CcSEcCtD
Fluvastatin—Insomnia—Prednisone—psoriasis	6.38e-05	0.000333	CcSEcCtD
Fluvastatin—Nausea—Cyclosporine—psoriasis	6.34e-05	0.000331	CcSEcCtD
Fluvastatin—Paraesthesia—Prednisone—psoriasis	6.34e-05	0.000331	CcSEcCtD
Fluvastatin—CYP3A4—Tryptophan metabolism—CAT—psoriasis	6.33e-05	0.00165	CbGpPWpGaD
Fluvastatin—Pruritus—Triamcinolone—psoriasis	6.32e-05	0.00033	CcSEcCtD
Fluvastatin—SLCO1B3—Transmembrane transport of small molecules—CARM1—psoriasis	6.31e-05	0.00165	CbGpPWpGaD
Fluvastatin—Cough—Methotrexate—psoriasis	6.31e-05	0.000329	CcSEcCtD
Fluvastatin—SLC15A1—Transmembrane transport of small molecules—CARM1—psoriasis	6.28e-05	0.00164	CbGpPWpGaD
Fluvastatin—Dizziness—Hydrocortisone—psoriasis	6.27e-05	0.000327	CcSEcCtD
Fluvastatin—Dyspepsia—Prednisone—psoriasis	6.21e-05	0.000324	CcSEcCtD
Fluvastatin—Nausea—Mycophenolate mofetil—psoriasis	6.19e-05	0.000323	CcSEcCtD
Fluvastatin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	6.17e-05	0.00161	CbGpPWpGaD
Fluvastatin—Chest pain—Methotrexate—psoriasis	6.15e-05	0.000321	CcSEcCtD
Fluvastatin—Arthralgia—Methotrexate—psoriasis	6.15e-05	0.000321	CcSEcCtD
Fluvastatin—Myalgia—Methotrexate—psoriasis	6.15e-05	0.000321	CcSEcCtD
Fluvastatin—Decreased appetite—Prednisone—psoriasis	6.14e-05	0.00032	CcSEcCtD
Fluvastatin—Rash—Prednisolone—psoriasis	6.13e-05	0.000319	CcSEcCtD
Fluvastatin—Dermatitis—Prednisolone—psoriasis	6.12e-05	0.000319	CcSEcCtD
Fluvastatin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	6.11e-05	0.000319	CcSEcCtD
Fluvastatin—Fatigue—Prednisone—psoriasis	6.09e-05	0.000317	CcSEcCtD
Fluvastatin—Headache—Prednisolone—psoriasis	6.09e-05	0.000317	CcSEcCtD
Fluvastatin—Discomfort—Methotrexate—psoriasis	6.08e-05	0.000317	CcSEcCtD
Fluvastatin—SLCO1B3—Metabolism—CYP2S1—psoriasis	6.05e-05	0.00158	CbGpPWpGaD
Fluvastatin—Constipation—Prednisone—psoriasis	6.04e-05	0.000315	CcSEcCtD
Fluvastatin—Vomiting—Hydrocortisone—psoriasis	6.03e-05	0.000315	CcSEcCtD
Fluvastatin—Rash—Hydrocortisone—psoriasis	5.98e-05	0.000312	CcSEcCtD
Fluvastatin—Dermatitis—Hydrocortisone—psoriasis	5.98e-05	0.000312	CcSEcCtD
Fluvastatin—Confusional state—Methotrexate—psoriasis	5.95e-05	0.00031	CcSEcCtD
Fluvastatin—Headache—Hydrocortisone—psoriasis	5.94e-05	0.00031	CcSEcCtD
Fluvastatin—CYP1A1—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	5.94e-05	0.00155	CbGpPWpGaD
Fluvastatin—Dizziness—Triamcinolone—psoriasis	5.91e-05	0.000308	CcSEcCtD
Fluvastatin—Anaphylactic shock—Methotrexate—psoriasis	5.9e-05	0.000308	CcSEcCtD
Fluvastatin—Infection—Methotrexate—psoriasis	5.86e-05	0.000306	CcSEcCtD
Fluvastatin—Feeling abnormal—Prednisone—psoriasis	5.82e-05	0.000303	CcSEcCtD
Fluvastatin—Asthenia—Dexamethasone—psoriasis	5.82e-05	0.000303	CcSEcCtD
Fluvastatin—Asthenia—Betamethasone—psoriasis	5.82e-05	0.000303	CcSEcCtD
Fluvastatin—Nervous system disorder—Methotrexate—psoriasis	5.79e-05	0.000302	CcSEcCtD
Fluvastatin—Thrombocytopenia—Methotrexate—psoriasis	5.78e-05	0.000301	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Prednisone—psoriasis	5.77e-05	0.000301	CcSEcCtD
Fluvastatin—Nausea—Prednisolone—psoriasis	5.77e-05	0.000301	CcSEcCtD
Fluvastatin—Pruritus—Dexamethasone—psoriasis	5.74e-05	0.000299	CcSEcCtD
Fluvastatin—Pruritus—Betamethasone—psoriasis	5.74e-05	0.000299	CcSEcCtD
Fluvastatin—Skin disorder—Methotrexate—psoriasis	5.73e-05	0.000299	CcSEcCtD
Fluvastatin—Hyperhidrosis—Methotrexate—psoriasis	5.7e-05	0.000297	CcSEcCtD
Fluvastatin—Vomiting—Triamcinolone—psoriasis	5.68e-05	0.000296	CcSEcCtD
Fluvastatin—Nausea—Hydrocortisone—psoriasis	5.64e-05	0.000294	CcSEcCtD
Fluvastatin—Rash—Triamcinolone—psoriasis	5.63e-05	0.000294	CcSEcCtD
Fluvastatin—Dermatitis—Triamcinolone—psoriasis	5.63e-05	0.000293	CcSEcCtD
Fluvastatin—Anorexia—Methotrexate—psoriasis	5.62e-05	0.000293	CcSEcCtD
Fluvastatin—Urticaria—Prednisone—psoriasis	5.61e-05	0.000292	CcSEcCtD
Fluvastatin—Headache—Triamcinolone—psoriasis	5.6e-05	0.000292	CcSEcCtD
Fluvastatin—Abdominal pain—Prednisone—psoriasis	5.58e-05	0.000291	CcSEcCtD
Fluvastatin—Body temperature increased—Prednisone—psoriasis	5.58e-05	0.000291	CcSEcCtD
Fluvastatin—Diarrhoea—Betamethasone—psoriasis	5.55e-05	0.000289	CcSEcCtD
Fluvastatin—Diarrhoea—Dexamethasone—psoriasis	5.55e-05	0.000289	CcSEcCtD
Fluvastatin—CYP1A2—Melatonin metabolism and effects—NFKB1—psoriasis	5.48e-05	0.00143	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—CYP2S1—psoriasis	5.46e-05	0.00142	CbGpPWpGaD
Fluvastatin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	5.45e-05	0.00142	CbGpPWpGaD
Fluvastatin—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	5.39e-05	0.00141	CbGpPWpGaD
Fluvastatin—Musculoskeletal discomfort—Methotrexate—psoriasis	5.38e-05	0.00028	CcSEcCtD
Fluvastatin—Dizziness—Betamethasone—psoriasis	5.36e-05	0.00028	CcSEcCtD
Fluvastatin—Dizziness—Dexamethasone—psoriasis	5.36e-05	0.00028	CcSEcCtD
Fluvastatin—Insomnia—Methotrexate—psoriasis	5.34e-05	0.000278	CcSEcCtD
Fluvastatin—Nausea—Triamcinolone—psoriasis	5.31e-05	0.000277	CcSEcCtD
Fluvastatin—Paraesthesia—Methotrexate—psoriasis	5.3e-05	0.000276	CcSEcCtD
Fluvastatin—Dyspnoea—Methotrexate—psoriasis	5.26e-05	0.000274	CcSEcCtD
Fluvastatin—UGT1A1—Metabolism—NDUFA5—psoriasis	5.22e-05	0.00136	CbGpPWpGaD
Fluvastatin—Hypersensitivity—Prednisone—psoriasis	5.2e-05	0.000271	CcSEcCtD
Fluvastatin—Dyspepsia—Methotrexate—psoriasis	5.19e-05	0.000271	CcSEcCtD
Fluvastatin—Vomiting—Dexamethasone—psoriasis	5.15e-05	0.000269	CcSEcCtD
Fluvastatin—Vomiting—Betamethasone—psoriasis	5.15e-05	0.000269	CcSEcCtD
Fluvastatin—Decreased appetite—Methotrexate—psoriasis	5.13e-05	0.000267	CcSEcCtD
Fluvastatin—Rash—Dexamethasone—psoriasis	5.11e-05	0.000267	CcSEcCtD
Fluvastatin—Rash—Betamethasone—psoriasis	5.11e-05	0.000267	CcSEcCtD
Fluvastatin—Dermatitis—Dexamethasone—psoriasis	5.11e-05	0.000266	CcSEcCtD
Fluvastatin—Dermatitis—Betamethasone—psoriasis	5.11e-05	0.000266	CcSEcCtD
Fluvastatin—Gastrointestinal disorder—Methotrexate—psoriasis	5.09e-05	0.000266	CcSEcCtD
Fluvastatin—Fatigue—Methotrexate—psoriasis	5.09e-05	0.000265	CcSEcCtD
Fluvastatin—Headache—Dexamethasone—psoriasis	5.08e-05	0.000265	CcSEcCtD
Fluvastatin—Headache—Betamethasone—psoriasis	5.08e-05	0.000265	CcSEcCtD
Fluvastatin—Asthenia—Prednisone—psoriasis	5.06e-05	0.000264	CcSEcCtD
Fluvastatin—Pain—Methotrexate—psoriasis	5.05e-05	0.000263	CcSEcCtD
Fluvastatin—Pruritus—Prednisone—psoriasis	4.99e-05	0.00026	CcSEcCtD
Fluvastatin—HMGCR—Integrated Breast Cancer Pathway—TP53—psoriasis	4.86e-05	0.00127	CbGpPWpGaD
Fluvastatin—Feeling abnormal—Methotrexate—psoriasis	4.86e-05	0.000254	CcSEcCtD
Fluvastatin—Diarrhoea—Prednisone—psoriasis	4.83e-05	0.000252	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Methotrexate—psoriasis	4.82e-05	0.000252	CcSEcCtD
Fluvastatin—Nausea—Betamethasone—psoriasis	4.81e-05	0.000251	CcSEcCtD
Fluvastatin—Nausea—Dexamethasone—psoriasis	4.81e-05	0.000251	CcSEcCtD
Fluvastatin—SLCO1B1—Metabolism—NDUFA5—psoriasis	4.78e-05	0.00125	CbGpPWpGaD
Fluvastatin—Urticaria—Methotrexate—psoriasis	4.69e-05	0.000244	CcSEcCtD
Fluvastatin—Dizziness—Prednisone—psoriasis	4.67e-05	0.000243	CcSEcCtD
Fluvastatin—Abdominal pain—Methotrexate—psoriasis	4.66e-05	0.000243	CcSEcCtD
Fluvastatin—Body temperature increased—Methotrexate—psoriasis	4.66e-05	0.000243	CcSEcCtD
Fluvastatin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	4.62e-05	0.00121	CbGpPWpGaD
Fluvastatin—CYP1A1—Aryl Hydrocarbon Receptor—TNF—psoriasis	4.62e-05	0.00121	CbGpPWpGaD
Fluvastatin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	4.55e-05	0.00119	CbGpPWpGaD
Fluvastatin—Vomiting—Prednisone—psoriasis	4.49e-05	0.000234	CcSEcCtD
Fluvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	4.46e-05	0.00116	CbGpPWpGaD
Fluvastatin—Rash—Prednisone—psoriasis	4.45e-05	0.000232	CcSEcCtD
Fluvastatin—Dermatitis—Prednisone—psoriasis	4.45e-05	0.000232	CcSEcCtD
Fluvastatin—SLCO1B1—Transmembrane transport of small molecules—CP—psoriasis	4.44e-05	0.00116	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—CYP2S1—psoriasis	4.44e-05	0.00116	CbGpPWpGaD
Fluvastatin—Headache—Prednisone—psoriasis	4.42e-05	0.000231	CcSEcCtD
Fluvastatin—Hypersensitivity—Methotrexate—psoriasis	4.35e-05	0.000227	CcSEcCtD
Fluvastatin—CYP1A1—PPARA activates gene expression—PPARG—psoriasis	4.33e-05	0.00113	CbGpPWpGaD
Fluvastatin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—psoriasis	4.24e-05	0.00111	CbGpPWpGaD
Fluvastatin—SLCO1B1—Transmembrane transport of small molecules—CARM1—psoriasis	4.24e-05	0.00111	CbGpPWpGaD
Fluvastatin—Asthenia—Methotrexate—psoriasis	4.23e-05	0.000221	CcSEcCtD
Fluvastatin—Nausea—Prednisone—psoriasis	4.19e-05	0.000219	CcSEcCtD
Fluvastatin—Pruritus—Methotrexate—psoriasis	4.17e-05	0.000218	CcSEcCtD
Fluvastatin—HMGCR—Metabolism of lipids and lipoproteins—APOE—psoriasis	4.13e-05	0.00108	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—CYP2S1—psoriasis	4.07e-05	0.00106	CbGpPWpGaD
Fluvastatin—Diarrhoea—Methotrexate—psoriasis	4.04e-05	0.000211	CcSEcCtD
Fluvastatin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	3.93e-05	0.00103	CbGpPWpGaD
Fluvastatin—Dizziness—Methotrexate—psoriasis	3.9e-05	0.000203	CcSEcCtD
Fluvastatin—HMGCR—Metabolism—CARM1—psoriasis	3.85e-05	0.001	CbGpPWpGaD
Fluvastatin—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	3.79e-05	0.000988	CbGpPWpGaD
Fluvastatin—Vomiting—Methotrexate—psoriasis	3.75e-05	0.000196	CcSEcCtD
Fluvastatin—Rash—Methotrexate—psoriasis	3.72e-05	0.000194	CcSEcCtD
Fluvastatin—Dermatitis—Methotrexate—psoriasis	3.72e-05	0.000194	CcSEcCtD
Fluvastatin—Headache—Methotrexate—psoriasis	3.7e-05	0.000193	CcSEcCtD
Fluvastatin—HMGCR—Metabolism of lipids and lipoproteins—PPARG—psoriasis	3.6e-05	0.000938	CbGpPWpGaD
Fluvastatin—Nausea—Methotrexate—psoriasis	3.5e-05	0.000183	CcSEcCtD
Fluvastatin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	3.44e-05	0.000897	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—NDUFA5—psoriasis	3.24e-05	0.000847	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—NDUFA5—psoriasis	3.17e-05	0.000828	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism of lipids and lipoproteins—APOE—psoriasis	3.17e-05	0.000828	CbGpPWpGaD
Fluvastatin—UGT1A3—Metabolism—CARM1—psoriasis	3.14e-05	0.000818	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—NDUFA5—psoriasis	3e-05	0.000782	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—CARM1—psoriasis	2.95e-05	0.000771	CbGpPWpGaD
Fluvastatin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	2.95e-05	0.000769	CbGpPWpGaD
Fluvastatin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	2.95e-05	0.000769	CbGpPWpGaD
Fluvastatin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—psoriasis	2.92e-05	0.000762	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.79e-05	0.000729	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.76e-05	0.000721	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—CYP2S1—psoriasis	2.76e-05	0.00072	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—NDUFA5—psoriasis	2.75e-05	0.000717	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—CYP2S1—psoriasis	2.7e-05	0.000704	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—CARM1—psoriasis	2.67e-05	0.000696	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.56e-05	0.000669	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—CYP2S1—psoriasis	2.55e-05	0.000665	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—NDUFA5—psoriasis	2.45e-05	0.00064	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism—CAT—psoriasis	2.37e-05	0.000617	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—CYP2S1—psoriasis	2.34e-05	0.00061	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.29e-05	0.000597	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—NDUFA5—psoriasis	2.26e-05	0.000589	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—NDUFA5—psoriasis	2.24e-05	0.000584	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—CARM1—psoriasis	2.17e-05	0.000565	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.13e-05	0.000556	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—CYP2S1—psoriasis	2.09e-05	0.000544	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.08e-05	0.000544	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—CARM1—psoriasis	1.99e-05	0.000518	CbGpPWpGaD
Fluvastatin—UGT1A3—Metabolism—CAT—psoriasis	1.93e-05	0.000503	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—CYP2S1—psoriasis	1.92e-05	0.000501	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—NDUFA5—psoriasis	1.91e-05	0.000499	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—CYP2S1—psoriasis	1.9e-05	0.000496	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.86e-05	0.000484	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism—APOE—psoriasis	1.84e-05	0.00048	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—CAT—psoriasis	1.82e-05	0.000474	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.78e-05	0.000465	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—CAT—psoriasis	1.64e-05	0.000428	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—CYP2S1—psoriasis	1.62e-05	0.000424	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism—PPARG—psoriasis	1.6e-05	0.000418	CbGpPWpGaD
Fluvastatin—UGT1A3—Metabolism—APOE—psoriasis	1.5e-05	0.000391	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—NDUFA5—psoriasis	1.47e-05	0.000385	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—APOE—psoriasis	1.41e-05	0.000369	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—CARM1—psoriasis	1.35e-05	0.000352	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.34e-05	0.000349	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—CAT—psoriasis	1.33e-05	0.000348	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—CARM1—psoriasis	1.32e-05	0.000344	CbGpPWpGaD
Fluvastatin—UGT1A3—Metabolism—PPARG—psoriasis	1.31e-05	0.000341	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—APOE—psoriasis	1.27e-05	0.000333	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—CYP2S1—psoriasis	1.25e-05	0.000327	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—CARM1—psoriasis	1.24e-05	0.000325	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—PPARG—psoriasis	1.23e-05	0.000321	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.22e-05	0.00032	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—CAT—psoriasis	1.22e-05	0.000319	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.16e-05	0.000304	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—CARM1—psoriasis	1.14e-05	0.000298	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—PPARG—psoriasis	1.11e-05	0.00029	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.09e-05	0.000285	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.07e-05	0.000278	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—APOE—psoriasis	1.04e-05	0.00027	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—CARM1—psoriasis	1.02e-05	0.000266	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	9.96e-06	0.00026	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	9.52e-06	0.000248	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—APOE—psoriasis	9.49e-06	0.000248	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—CARM1—psoriasis	9.37e-06	0.000244	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—CARM1—psoriasis	9.28e-06	0.000242	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—PPARG—psoriasis	9.02e-06	0.000235	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	8.68e-06	0.000227	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	8.51e-06	0.000222	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—CAT—psoriasis	8.29e-06	0.000216	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—PPARG—psoriasis	8.26e-06	0.000216	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—CAT—psoriasis	8.1e-06	0.000211	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—CARM1—psoriasis	7.93e-06	0.000207	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—CAT—psoriasis	7.65e-06	0.0002	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	7.42e-06	0.000194	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—CAT—psoriasis	7.02e-06	0.000183	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—APOE—psoriasis	6.44e-06	0.000168	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—APOE—psoriasis	6.29e-06	0.000164	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—CAT—psoriasis	6.26e-06	0.000163	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—CARM1—psoriasis	6.12e-06	0.00016	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—APOE—psoriasis	5.95e-06	0.000155	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—CAT—psoriasis	5.76e-06	0.00015	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—CAT—psoriasis	5.71e-06	0.000149	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—PPARG—psoriasis	5.61e-06	0.000146	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—PPARG—psoriasis	5.48e-06	0.000143	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—APOE—psoriasis	5.45e-06	0.000142	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—PPARG—psoriasis	5.18e-06	0.000135	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—CAT—psoriasis	4.88e-06	0.000127	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—APOE—psoriasis	4.87e-06	0.000127	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—PPARG—psoriasis	4.75e-06	0.000124	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—APOE—psoriasis	4.48e-06	0.000117	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—APOE—psoriasis	4.44e-06	0.000116	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—PPARG—psoriasis	4.24e-06	0.000111	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—PPARG—psoriasis	3.9e-06	0.000102	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—PPARG—psoriasis	3.86e-06	0.000101	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—APOE—psoriasis	3.79e-06	9.9e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—CAT—psoriasis	3.77e-06	9.83e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—PPARG—psoriasis	3.3e-06	8.62e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—APOE—psoriasis	2.93e-06	7.64e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—PPARG—psoriasis	2.55e-06	6.65e-05	CbGpPWpGaD
